We Spent $724,637 Testing Rapamycin. What We Found Shocked Us.
The video details a five‑year, $724,637 crowdfunded clinical trial that tested whether weekly rapamycin, combined with home‑based cycling exercise, could improve muscle performance in adults aged 65‑85. Results were published in the Journal of Cexia Psychopenia and Muscle, and the investigators emphasize the study’s rigorous, pre‑registered design. Forty participants were randomized to receive either 6 mg rapamycin or placebo, exercising on stationary bikes three times per week for 12 weeks. The primary endpoint, the 30‑second chair‑stand test, did not reach statistical significance; the placebo group actually trended toward greater improvement. Sensitivity analyses (case‑complete and per‑protocol) reinforced this trend, and secondary measures such as the 6‑minute walk and hand‑grip strength showed similar, non‑significant patterns favoring placebo. Co‑author Professor Matt Kaline highlighted rapamycin’s reputation as a “gold‑standard” anti‑aging drug and explained the mechanistic hypothesis: intermittent mTOR inhibition could restore autophagy in aged muscle. He also cautioned against over‑interpreting the findings, noting the study’s limited sample size and the inherent variability of human performance data. The unexpected attenuation of exercise gains by rapamycin suggests that the current weekly dosing schedule may be suboptimal for healthy older adults. The trial underscores the need for larger, longer‑duration studies to clarify rapamycin’s role in human healthspan and to refine dosing protocols before broader clinical adoption.
The 'Toxic' Hormone That Just Broke Every Obesity Record
The video examines retatrutide, Eli Lilly’s triple‑hormone receptor agonist that activates GLP‑1, GIP and glucagon. By turning on all three pathways, the drug has shattered obesity‑treatment records, delivering average weight losses of 24‑28% in phase‑3 trials—far exceeding the 15‑20% achieved by...
The 60-Year Cholesterol War Is Finally Over
The video chronicles the resolution of a six‑decade debate over cholesterol management, tracing its origins to a 2006 Dallas Heart Study discovery of a woman with an LDL of 14 mg/dL caused by PCSK9 loss‑of‑function mutations. Researchers realized that silencing PCSK9...
This $2 Remedy Beats Every Cold Medicine
The video examines three inexpensive, evidence‑based remedies—zinc acetate lozenges, saline nasal irrigation, and honey—that actually shorten the common cold, contrasting them with popular but ineffective supplements like vitamin C or echinacea. Clinical data show zinc acetate lozenges reduce illness length by...
The Anti-Aging Supplement Scam (New Evidence)
The video exposes how the Interventions Testing Program (ITP) debunks popular anti‑aging supplement claims by subjecting them to triple‑site mouse trials, highlighting recent findings that overturn hype around products like Aazanthin and calcium‑alpha‑ketoglutarate (AKG). In 2023 the ITP reported a 12 %...
New Study Says I Was Wrong About NMN and NR?
The video dissects the ongoing NMN versus NR debate, highlighting a recent Bergen study that touted a 2.3‑fold NAD boost from NR. While the author initially presents the headline claim, he quickly pivots to larger, more robust data that undercuts...
I Got a Full-Body MRI. Here's Why You Shouldn't.
The video examines the surge in commercial full‑body MRI scans, a market buoyed by celebrity endorsements and a luxury‑spa experience, despite explicit guidance from the American College of Radiology that advises against such routine imaging for asymptomatic individuals. It highlights...
Completely WRONG About Salt (New Study)
The video dissects a new umbrella review – essentially a meta‑analysis of meta‑analyses – that aggregates decades of randomized trials and observational studies on dietary sodium. The authors argue that the latest synthesis finally settles the long‑standing debate: lower...
Best Diet Confirmed by 5,248,916 Person-Year Study
The video dissects a new, 30‑year observational study of roughly 200,000 participants that finally pits low‑fat against low‑carb eating patterns while accounting for food quality. By separating "healthy" from "unhealthy" versions of each diet—using plant‑based proteins, whole grains, and unsaturated...
Your Skin Loses 75% of This by Age 75 (New Fix)
The video examines whether oral hyaluronic acid (HA) supplements can counteract the dramatic loss of HA in skin—by age 75 people retain only about a quarter of the levels found at age 19. It reviews past absorption doubts and highlights...
Doctor Reveals the Nitric Oxide Booster He Takes
The video examines how nitric‑oxide (NO) production wanes with age and why many consumers are drawn to over‑the‑counter “NO boosters.” The doctor explains that while prescription NO donors such as glyceryl trinitrate or isosorbide mononitrate provide rapid vasodilation, the body...
More Exercise, More Plaque?
The video examines a newly published study that finds athletes who log high‑intensity, high‑volume endurance training are almost six times more likely to develop arterial plaque than low‑volume peers, challenging the long‑standing belief that more exercise always means healthier arteries. The...
Ridiculously Cheap Ways to Treat Skin Aging
The video outlines a low‑cost, evidence‑based regimen to slow skin aging, covering nutrition, physical activity, sleep hygiene, sun protection, and topical retinoids. Research shows that diets high in vitamin C, phytonutrients and plant‑based proteins improve skin appearance, while high‑fat and refined‑sugar foods...
What Microneedling REALLY Does for Skin Aging
The video examines whether microneedling delivers on its promise to reverse skin aging, tracing the technique from a 1997 scar‑treatment paper to today’s at‑home derma rollers and professional pens. Clinical evidence shows measurable benefits: a 480‑patient trial reported 60‑80 % self‑assessed improvement...